Clinical Data Delivers Vilazodone Milestone Payment to Merck KGaA
NEWTON, Mass.--Clinical Data, Inc. (NASDAQ:CLDA), which is focused on developing new predictive tests and targeted therapeutics from its growing portfolio of proprietary genetic biomarkers, today announced that it has made a milestone payment to Merck KGaA …